← Back to headlines
Outlook Therapeutics (OTLK) Receives July 29 PDUFA Date for LYTENAVA
Outlook Therapeutics (OTLK) has been assigned a PDUFA date of July 29 for its drug candidate LYTENAVA, a key regulatory milestone.
14 Jul, 18:08 — 14 Jul, 18:08
Sources
Showing 1 of 1 sources
Related Stories
Japan Household Spending Drops 3.6% in July for Eighth Consecutive Month
24m ago
US Probes Deadly Strike on Iranian Wedding Linked to American Munitions
36m ago
Volkswagen Approves Plan to Cut 100,000 Jobs and Halve Vehicle Lineup
39m ago
Trump Administration Asks Supreme Court to Allow Mail-In Voting Restrictions
39m ago